InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,095.60
(
2.05%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.58
(
0.01%
)
Bitcoin
67,002.86
(
0.89%
)
Post# of 2104
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Inoviorulez

Send PM Follow Ignore
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Inoviorulez

Re: biotech2010 post# 1056

Wednesday, 01/04/2017 10:46:44 PM

Wednesday, January 04, 2017 10:46:44 PM

Post# of 2104
Yes the main catalyst is once the phase 2b LC trial starts. Because thats when Novartis chooses to take the option to fully license emricasan. Although until then we also might have a nice surprise with respect to ad hoc data as well.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM

BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM

Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM

Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM

Start posting your company's news
Only $200 per official company press release!